SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001845459-23-000013
Filing Date
2023-11-14
Accepted
2023-11-14 16:36:05
Documents
15
Period of Report
2023-11-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nkgn-20231114.htm   iXBRL 8-K 32793
2 EX-99.1 nkgenq323earningsrelease.htm EX-99.1 103602
7 imagea.jpg GRAPHIC 41487
  Complete submission text file 0001845459-23-000013.txt   375056

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nkgn-20231114.xsd EX-101.SCH 2288
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nkgn-20231114_def.xml EX-101.DEF 15959
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nkgn-20231114_lab.xml EX-101.LAB 30801
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nkgn-20231114_pre.xml EX-101.PRE 16697
9 EXTRACTED XBRL INSTANCE DOCUMENT nkgn-20231114_htm.xml XML 4077
Mailing Address 3001 DAIMLER ST, SANTA ANA CA 92705
Business Address 3001 DAIMLER ST, SANTA ANA CA 92705 (949) 396-6830
NKGen Biotech, Inc. (Filer) CIK: 0001845459 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40427 | Film No.: 231407195
SIC: 2836 Biological Products, (No Diagnostic Substances)